Implantation of Bioactive Growth Factor-Secreting Rods Enhances Fetal Dopaminergic Graft Survival, Outgrowth Density, and Functional Recovery in a Rat Model of Parkinson's Disease
- 1 July 2000
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 164 (1), 130-138
- https://doi.org/10.1006/exnr.2000.7411
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Lazaroid-enhanced survival of grafted dopamine neurons does not increase target innervationNeuroReport, 1998
- Tirilazad Mesylate Increases Dopaminergic Neuronal Survival in thein OculoGrafting ModelExperimental Neurology, 1997
- The Time Course of Loss of Dopaminergic Neurons and the Gliotic Reaction Surrounding Grafts of Embryonic Mesencephalon to the StriatumExperimental Neurology, 1996
- Tempting Fate and Commitment in the Developing ForebrainNeuron, 1996
- Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brainNature, 1995
- Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human.Proceedings of the National Academy of Sciences, 1991
- Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatumExperimental Brain Research, 1987
- Intrastriatal grafting of dopamine-containing neuronal cell suspensions: Effects of mixing with target or non-target cellsDevelopmental Brain Research, 1986
- Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplantsBrain Research, 1979
- Estimation of nuclear population from microtome sectionsThe Anatomical Record, 1946